RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 173 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $223,000 | +254.0% | 5,449 | +277.4% | 0.00% | – |
| Q1 2024 | $63,000 | -91.5% | 1,444 | -91.0% | 0.00% | – |
| Q4 2023 | $743,000 | +169.2% | 16,132 | +34.0% | 0.00% | – |
| Q3 2023 | $276,000 | +130.0% | 12,043 | +66.1% | 0.00% | – |
| Q2 2023 | $120,000 | +242.9% | 7,249 | +269.3% | 0.00% | – |
| Q1 2023 | $35,000 | +600.0% | 1,963 | +1028.2% | 0.00% | – |
| Q4 2022 | $5,000 | +150.0% | 174 | +167.7% | 0.00% | – |
| Q3 2022 | $2,000 | -93.8% | 65 | -97.7% | 0.00% | – |
| Q1 2022 | $32,000 | -62.4% | 2,796 | -67.2% | 0.00% | – |
| Q4 2021 | $85,000 | +41.7% | 8,531 | +86.3% | 0.00% | – |
| Q3 2021 | $60,000 | -27.7% | 4,580 | +8.6% | 0.00% | – |
| Q2 2021 | $83,000 | +2.5% | 4,217 | +10.5% | 0.00% | – |
| Q1 2021 | $81,000 | +305.0% | 3,815 | +482.4% | 0.00% | – |
| Q4 2020 | $20,000 | +400.0% | 655 | +227.5% | 0.00% | – |
| Q3 2020 | $4,000 | +100.0% | 200 | +65.3% | 0.00% | – |
| Q1 2020 | $2,000 | -95.0% | 121 | -93.1% | 0.00% | – |
| Q4 2019 | $40,000 | – | 1,752 | +34940.0% | 0.00% | – |
| Q1 2019 | $0 | – | 5 | +150.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2 | -99.5% | 0.00% | – |
| Q3 2018 | $12,000 | +1100.0% | 426 | +826.1% | 0.00% | – |
| Q2 2018 | $1,000 | -66.7% | 46 | -56.6% | 0.00% | – |
| Q4 2017 | $3,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
| NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
| Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
| RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
| Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
| Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
| Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
| HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
| Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
| GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |